What AI says about Duvyzat

Duvyzat is a nonsteroidal treatment indicated for Duchenne muscular dystrophy in people aged 6 years and older, regardless of genetic variant or ambulatory status.

AI mentioned Duvyzat from October 2025 to March 2026.